Show simple item record

dc.contributor.authorChambers, Suzanne K
dc.contributor.authorZajdlewicz, Leah
dc.contributor.authorYoulden, Danny R
dc.contributor.authorHolland, Jimmie C
dc.contributor.authorDunn, Jeff
dc.date.accessioned2017-05-03T14:37:21Z
dc.date.available2017-05-03T14:37:21Z
dc.date.issued2014
dc.date.modified2014-08-05T23:03:15Z
dc.identifier.issn1057-9249
dc.identifier.doi10.1002/pon.3391
dc.identifier.urihttp://hdl.handle.net/10072/61892
dc.description.abstractBackground: The Distress Thermometer (DT) is widely recommended for screening for distress after cancer. However, the validity of the DT in men with prostate cancer and over differing time points from diagnosis has not been well examined. Method: Receiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT compared with three commonly used standardised scales in two prospective and one crosssectional survey of men with prostate cancer (n = 740, 189 and 463, respectively). Comparison scales included the Impact of Event Scale - Revised (IES-R, Study 1), the Hospital Anxiety and Depression Scale (HADS, Study 2) and the Brief Symptom Inventory-18 (BSI-18, Study 3). Results: Study 1: the DT showed good accuracy against the IES-R at all time points (area under curves (AUCs) ranging from 0.84 to 0.88) and sensitivity was high (>85%). Study 2: the DT performed well against both the anxiety and depression subscales for HADS at baseline (AUC = 0.84 and 0.82, respectively), but sensitivity decreased substantially after 12 months. Study 3: validity was high for the anxiety (AUC = 0.90, sensitivity = 90%) and depression (AUC = 0.85, sensitivity = 74%) subscales of the BSI-18 but was poorer for somatization (AUC = 0.67, sensitivity = 52%). A DT cutoff between =3 and =6 maximised sensitivity and specificity across analyses. Conclusions: The DT is a valid tool to detect cancer-specific distress, anxiety and depression among prostate cancer patients, particularly close to diagnosis. A cut-off of =4 may be optimal soon after diagnosis, and for longer-term assessments, =3 was supported.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherJohn Wiley & Sons
dc.publisher.placeUnited Kingdom
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom195
dc.relation.ispartofpageto203
dc.relation.ispartofissue2
dc.relation.ispartofjournalPsycho-Oncology
dc.relation.ispartofvolume23
dc.rights.retentionY
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchOncology and carcinogenesis
dc.subject.fieldofresearchOncology and carcinogenesis not elsewhere classified
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode3211
dc.subject.fieldofresearchcode321199
dc.titleThe Validity of the Distress Thermometer in Prostate Cancer Populations
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Applied Psychology
gro.hasfulltextNo Full Text
gro.griffith.authorChambers, Suzanne K.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record